论文部分内容阅读
根据一项新的试验研究显示，干扰素β可降低次级进展性多发性硬化症（ｓｅｃｏｎｄａｒｙｐｒｏｇｒｅｓｓｉｖｅｍｕｌｔｉｐｌｅｓｃｌｅｒｏｓｉｓ，ＳＰＭＳ）的疾病进程，这是目前第一个显示对ＳＰＭＳ有治疗作用的药物。在欧洲进行的Ⅲ期临床试验中，７１８名受试者每
According to a new experimental study, interferon β can reduce the disease progression of secondary progressive multiple sclerosis (SPMS), which is currently the first drug to show a therapeutic effect on SPMS. In Phase III clinical trials in Europe, 718 subjects each